相似文献
1
Polymer nanoparticles for drug and small silencing RNA delivery to treat cancers of different phenotypes.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014 Jan-Feb;6(1):40-60. doi: 10.1002/wnan.1242. Epub 2013 Aug 31.
2
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Eur J Pharm Biopharm. 2015 Jun;93:52-79. doi: 10.1016/j.ejpb.2015.03.018. Epub 2015 Mar 23.
3
Recent advances in siRNA delivery for cancer therapy using smart nanocarriers.
Drug Discov Today. 2018 Apr;23(4):900-911. doi: 10.1016/j.drudis.2018.01.042. Epub 2018 Jan 31.
4
Theranostic Nanoparticles for RNA-Based Cancer Treatment.
Acc Chem Res. 2019 Jun 18;52(6):1496-1506. doi: 10.1021/acs.accounts.9b00101. Epub 2019 May 28.
5
Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
World J Gastroenterol. 2015 Nov 14;21(42):12022-41. doi: 10.3748/wjg.v21.i42.12022.
6
Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine.
Curr Top Med Chem. 2019;19(27):2507-2523. doi: 10.2174/1568026619666191024170212.
7
A strategy using mesoporous polymer nanospheres as nanocarriers of Bcl-2 siRNA towards breast cancer therapy.
J Mater Chem B. 2019 Jan 21;7(3):477-487. doi: 10.1039/c8tb02463d. Epub 2018 Dec 20.
8
Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
Acc Chem Res. 2018 Nov 20;51(11):2848-2856. doi: 10.1021/acs.accounts.8b00195. Epub 2018 Oct 15.
9
Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
Acc Chem Res. 2011 Oct 18;44(10):1080-93. doi: 10.1021/ar200011r. Epub 2011 Jul 26.
10
Silencing of survivin and cyclin B1 through siRNA-loaded arginine modified calcium phosphate nanoparticles for non-small-cell lung cancer therapy.
Colloids Surf B Biointerfaces. 2020 Dec;196:111340. doi: 10.1016/j.colsurfb.2020.111340. Epub 2020 Aug 27.
引用本文的文献
1
Membrane-modified lipid nanoparticles for RNA delivery.
Mol Ther Methods Clin Dev. 2025 Jun 9;33(3):101505. doi: 10.1016/j.omtm.2025.101505. eCollection 2025 Sep 11.
2
Gold Nanoparticles Synthesized with Triple-Negative Breast Cancer Cell Lysate Enhance Antitumoral Immunity: A Novel Synthesis Method.
Pharmaceuticals (Basel). 2025 Feb 26;18(3):330. doi: 10.3390/ph18030330.
3
The Plethora of RNA-Protein Interactions Model a Basis for RNA Therapies.
Genes (Basel). 2025 Jan 2;16(1):48. doi: 10.3390/genes16010048.
4
RNA Structure: Past, Future, and Gene Therapy Applications.
Int J Mol Sci. 2024 Dec 26;26(1):110. doi: 10.3390/ijms26010110.
5
Gemcitabine and synthesized silver nanoparticles impact on chemically induced hepatocellular carcinoma in male rats.
Int J Immunopathol Pharmacol. 2024 Jan-Dec;38:3946320241263352. doi: 10.1177/03946320241263352.
6
Challenges and advances of the stability of mRNA delivery therapeutics.
Nucl Acid Insights. 2024 Mar;1(2):101-113. doi: 10.18609/nai.2024.015. Epub 2024 Mar 13.
7
The Multifaceted Role of miR-21 in Pancreatic Cancers.
Cells. 2024 May 30;13(11):948. doi: 10.3390/cells13110948.
8
Chitosan/Alginate-Based Nanoparticles for Antibacterial Agents Delivery.
Int J Nanomedicine. 2024 May 30;19:5021-5044. doi: 10.2147/IJN.S469572. eCollection 2024.
9
Nanotechnology Integrated Innovative Drug Delivery and Therapy for Cancer.
Curr Pharm Biotechnol. 2024 Apr 22. doi: 10.2174/0113892010279483240417050548.
10
Fabrication of Nanocrystals for Enhanced Distribution of a Fatty Acid Synthase Inhibitor (Orlistat) as a Promising Method to Relieve Solid Ehrlich Carcinoma-Induced Hepatic Damage in Mice.
Pharmaceuticals (Basel). 2024 Jan 10;17(1):96. doi: 10.3390/ph17010096.
本文引用的文献
1
Design of Nanoparticles as Drug Carriers for Cancer Therapy.
Cancer Genomics Proteomics. 2006 May-Aug;3(3-4):147-157. Epub 2006 Jan 1.
2
Toxicology and clinical potential of nanoparticles.
Nano Today. 2011 Dec;6(6):585-607. doi: 10.1016/j.nantod.2011.10.001.
3
Galactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects.
World J Gastroenterol. 2012 Nov 14;18(42):6076-87. doi: 10.3748/wjg.v18.i42.6076.
4
Targeted delivery of biodegradable nanoparticles with ultrasound-targeted microbubble destruction-mediated hVEGF-siRNA transfection in human PC-3 cells in vitro.
Int J Mol Med. 2013 Jan;31(1):163-71. doi: 10.3892/ijmm.2012.1175. Epub 2012 Nov 8.
5
5-Fluorouracil nanoparticles inhibit hepatocellular carcinoma via activation of the p53 pathway in the orthotopic transplant mouse model.
PLoS One. 2012;7(10):e47115. doi: 10.1371/journal.pone.0047115. Epub 2012 Oct 15.
6
Toxicological aspects for nanomaterial in humans.
Methods Mol Biol. 2013;948:1-12. doi: 10.1007/978-1-62703-140-0_1.
7
Low-molecular weight chitosan/vascular endothelial growth factor short hairpin RNA for the treatment of hepatocellular carcinoma.
Life Sci. 2012 Dec 10;91(23-24):1207-15. doi: 10.1016/j.lfs.2012.09.015. Epub 2012 Oct 5.
8
Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats.
Colloids Surf B Biointerfaces. 2013 Jan 1;101:353-60. doi: 10.1016/j.colsurfb.2012.06.024. Epub 2012 Jun 28.
9
Mechanistic studies of Gemcitabine-loaded nanoplatforms in resistant pancreatic cancer cells.
BMC Cancer. 2012 Sep 22;12:419. doi: 10.1186/1471-2407-12-419.
10
Synthesis and characterization of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles as a sustained-release anticancer drug delivery system.
Appl Biochem Biotechnol. 2012 Nov;168(6):1434-47. doi: 10.1007/s12010-012-9868-4. Epub 2012 Sep 14.
Zotero 插件